Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Apple
AAPL
|
+$4.25B |
| 2 |
Broadcom
AVGO
|
+$2.83B |
| 3 |
Gilead Sciences
GILD
|
+$1.23B |
| 4 |
Fidelity Investment Grade Securitized ETF
FSEC
|
+$1.1B |
| 5 |
Carvana
CVNA
|
+$1.02B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$5.61B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
lululemon athletica
LULU
|
+$1.96B |
| 4 |
Eaton
ETN
|
+$1.67B |
| 5 |
ASML
ASML
|
+$1.6B |
Sector Composition
| 1 | Technology | 30.95% |
| 2 | Healthcare | 12.13% |
| 3 | Financials | 11.25% |
| 4 | Communication Services | 10.78% |
| 5 | Consumer Discretionary | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Arbutus Biopharma
ABUS
$849M
| $321K | ﹤0.01% |
83,280
-17,538
| -17% | -$67.5K |
|
2852
Visteon
VC
$3.41B
| $319K | ﹤0.01% |
3,354
+1,582
| +89% | +$151K |
|
2853
iShares US Equity Factor ETF
LRGF
$2.89B
| $319K | ﹤0.01% |
5,434
+2,670
| +97% | +$157K |
|
2854
Dorian LPG
LPG
$1.37B
| $319K | ﹤0.01% |
9,274
-562
| -6% | -$19.3K |
|
2855
Fox Factory Holding Corp
FOXF
$1.09B
| $318K | ﹤0.01% |
7,674
+3,045
| +66% | +$126K |
|
2856
Invesco S&P MidCap Low Volatility ETF
XMLV
$804M
| $318K | ﹤0.01% |
5,217
+1,774
| +52% | +$108K |
|
2857
MiMedx Group
MDXG
$1.03B
| $318K | ﹤0.01% |
53,869
+12,371
| +30% | +$73.1K |
|
2858
SPDR MSCI USA StrategicFactors ETF
QUS
$1.58B
| $317K | ﹤0.01% |
2,013
+734
| +57% | +$116K |
|
2859
Core Laboratories
CLB
$585M
| $316K | ﹤0.01% |
17,057
+11,028
| +183% | +$204K |
|
2860
Marriott Vacations Worldwide
VAC
$2.62B
| $315K | ﹤0.01% |
4,281
-705,385
| -99% | -$51.8M |
|
2861
Altimmune
ALT
$315M
| $314K | ﹤0.01% |
51,060
+43,166
| +547% | +$265K |
|
2862
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.69B
| $311K | ﹤0.01% |
5,793
+471
| +9% | +$25.3K |
|
2863
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.18B
| $310K | ﹤0.01% |
2,648
+205
| +8% | +$24K |
|
|
AMED
2864
DELISTED
Amedisys
AMED
| $310K | ﹤0.01% |
3,213
-3,283
| -51% | -$317K |
|
2865
Azenta
AZTA
$1.4B
| $310K | ﹤0.01% |
6,391
-676
| -10% | -$32.7K |
|
|
ALEX
2866
Alexander & Baldwin
ALEX
$1.35B
| $309K | ﹤0.01% |
16,080
+9,746
| +154% | +$187K |
|
2867
ACM Research
ACMR
$2.17B
| $308K | ﹤0.01% |
15,185
+12,685
| +507% | +$258K |
|
2868
Burford Capital
BUR
$2.81B
| $308K | ﹤0.01% |
23,284
+22,192
| +2,032% | +$294K |
|
2869
FlexShares Quality Dividend Defensive Index Fund
QDEF
$473M
| $308K | ﹤0.01% |
4,305
-1
| -0% | -$72 |
|
2870
Karyopharm Therapeutics
KPTI
$52.7M
| $307K | ﹤0.01% |
24,648
+5,100
| +26% | +$63.5K |
|
2871
Global Net Lease
GNL
$1.79B
| $306K | ﹤0.01% |
36,370
+3,675
| +11% | +$30.9K |
|
2872
iShares Morningstar Mid-Cap Value ETF
IMCV
$833M
| $306K | ﹤0.01% |
3,993
+1,052
| +36% | +$80.6K |
|
2873
Solid Biosciences
SLDB
$426M
| $305K | ﹤0.01% |
+43,761
| New | +$305K |
|
2874
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$5.03B
| $305K | ﹤0.01% |
5,751
+64
| +1% | +$3.39K |
|
2875
Banc of California
BANC
$2.59B
| $304K | ﹤0.01% |
20,659
+1,126
| +6% | +$16.6K |
|